Alcon announced AcrySof® IQ PanOptix® Trifocal Intraocular Lens (IOL) has successfully surpassed more than one million implants worldwide. In order to mark this achievement, Alcon is launching a new “One Million Moments- Thank You” ad campaign that that showcases the recognition of the positive impact that the Eye Care Professionals (ECPs) have made on their patients who have been implanted with PanOptix. The objective of this campaign is to bring to life the thank you moments between a patient and ECP.

“When we launched PanOptix, we knew that bringing this trifocal IOL to ophthalmologists around the world would have a significant impact on cataract patients,” said Alex Long, Alcon’s Global Vice President of Cataract Implantables. “In recognizing one million PanOptix implants, we want to say ‘thank you’ to the ophthalmology community for continuing to care for cataract patients around the world, helping deliver not only their need for restored vision, but also vision correction to support their lifestyle needs and preferences. The impact this IOL continues to have on patients’ lives and the testimonials we have received through the years inspire us to continue to help even more patients see brilliantly.”

For this milestone, the impact of PanOptix was recognized with Alcon receiving the “Best Medical Technology” award for the 50th Prix Galien USA. Largely considered the Nobel Prize of the biopharmaceutical and medical technology industries, Prix Galien honors innovations that improve the human condition. This is the latest award for PanOptix, which has won other accolades in the past, including the “Business Intelligence Group (BIG) Innovation” award.

“Receiving the Prix Galien is a testament to the impact PanOptix has on the quality of life of cataract patients worldwide – with 99% stating they would choose the same lens again,” said Rob Scott, Vice President, Intraocular Devices R&D, Alcon. “I’m incredibly proud of Alcon’s research and development team who solved a significant need in the market with PanOptix – to create a trifocal IOL with three optimally placed focal points. As an industry leader in IOLs, we will continue to innovate in this area to bring surgeons and their patients across the globe advanced technologies in ophthalmology.”

PanOptix IOL utilizes advanced ENLIGHTEN® Optical Technology, a proprietary design that optimizes intermediate vision without compromising exceptional near and distance vision. The ENLIGHTEN technology allows people to see better in both bright and dim conditions – both day and night – by providing a meaningful high total light utilization.

For for information, visit https://www.alcon.com/